公开(公告)号：US20190224258A1

公开(公告)日：2019-07-25

申请号：US16379634

申请日：2019-04-09

Applicant: CJ CHEILJEDANG CORPORATION

Inventor： Eun Mi SHIN ,  Gi Duk BAE ,  Jae Won KIM

IPC: A61K35/76 ,  A23K50/75 ,  A23K10/18 ,  C12N7/00 ,  A23K20/195 ,  A23K50/70 ,  A23K20/153

Abstract: The present invention relates to a novel bacteriophage ΦCJ24 (KCCM11462P) and a composition comprising the same as an active component. In addition, the present invention relates to a method for preventing and/or treating infectious diseases caused by avian pathogenic E. coli of birds by using the bacteriophage ΦCJ24 (KCCM11462P) or the composition.

公开(公告)号：US20170189460A1

公开(公告)日：2017-07-06

申请号：US15304429

申请日：2015-04-14

Applicant: CJ CHEILJEDANG CORPORATION

Inventor： Eun Mi SHIN ,  Bo Kyung SON ,  Gi Duk BAE ,  Jae Won KIM

IPC: A61K35/76 ,  C12N7/00

CPC classification number: A61K35/76 ,  A23K10/18 ,  A23K20/153 ,  A23K20/195 ,  A23K50/70 ,  A23K50/75 ,  C12N7/00 ,  C12N2795/10321 ,  C12N2795/10332

Abstract: The present invention relates to a novel bacteriophage ΦCJ26 (KCCM11464P) and a composition comprising the same as an active ingredient. In addition, the present invention relates to a method for preventing and/or treating infectious diseases caused by Salmonella by using the bacteriophage ΦCJ26 (KCCM11464P) or the composition.

公开(公告)号：US20160083697A1

公开(公告)日：2016-03-24

申请号：US14770429

申请日：2014-02-24

Applicant: CJ CHEILJEDANG CORPORATION

Inventor： Eun Mi SHIN ,  Gi Duk BAE ,  Jae Won KIM

IPC: C12N7/00 ,  A61K35/76 ,  A23K1/17 ,  A01N63/00

CPC classification number: C12N7/00 ,  A01N63/00 ,  A23K10/18 ,  A23K20/195 ,  A23K50/30 ,  A23L2/44 ,  A23L3/3463 ,  A61K35/76 ,  C12N2795/10221 ,  C12N2795/10231 ,  C12N2795/10233

Abstract: Provided is a novel bacteriophage ΦCJ20 (KCCM11362P). In addition, the present invention relates to an antibacterial composition including the bacteriophage ΦCJ20 (KCCM11362P) as an active ingredient. Further, the present invention is a method of preventing and/or treating infectious diseases by enterotoxigenic Escherichia coli in animals except for humans using the bacteriophage ΦCJ20 (KCCM11362P) or the antibacterial composition containing the bacteriophage ΦCJ20 (KCCM11362P) as an active ingredient.

Abstract translation: 提供了一种新型噬菌体ΦCJ20（KCCM11362P）。 此外，本发明涉及包含噬菌体ΦCJ20（KCCM11362P）作为活性成分的抗菌组合物。 此外，本发明是使用噬菌体ΦCJ20（KCCM11362P）或含有噬菌体ΦCJ20（KCCM11362P）的抗菌组合物作为活性成分的除了人以外的动物中的肠致毒性大肠杆菌的预防和/或治疗感染性疾病的方法。

公开(公告)号：US20160083695A1

公开(公告)日：2016-03-24

申请号：US14770328

申请日：2014-02-25

Applicant: CJ CHEILJEDANG CORPORATION

Inventor： Hyo Seel SEO ,  Eun Mi SHIN ,  Gi Duk BAE ,  Jae Won KIM

IPC: C12N7/00 ,  A23K1/18 ,  C11D3/48 ,  A61K35/76 ,  A01N63/00

CPC classification number: C12N7/00 ,  A01N63/00 ,  A23K50/75 ,  A61K35/76 ,  C11D3/48 ,  C12N2795/00021 ,  C12N2795/00031 ,  C12N2795/00032 ,  C12N2795/10221 ,  C12N2795/10222 ,  C12N2795/10231 ,  Y02A50/473

Abstract: Provided is a novel bacteriophage ΦCJ23 (KCCM11365P). In addition, the present invention relates to an antibacterial composition including the bacteriophage ΦCJ23 (KCCM11365P) as an active ingredient. Further, provided is a method of preventing and/or treating infectious diseases by avian pathogenic Escherichia coli (APEC) in birds using the bacteriophage ΦCJ23(KCCM11365P) or the antibacterial composition containing the bacteriophage ΦCJ23(KCCM11365P) as an active ingredient.

Abstract translation: 提供了一种新型噬菌体ΦCJ23（KCCM11365P）。 此外，本发明涉及包含噬菌体ΦCJ23（KCCM11365P）作为活性成分的抗菌组合物。 此外，提供了使用噬菌体ΦCJ23（KCCM11365P）或含有噬菌体ΦCJ23（KCCM11365P）的抗菌组合物作为活性成分的禽类致病性大肠杆菌（APEC）在禽中的预防和/或治疗感染性疾病的方法。

公开(公告)号：US20160076004A1

公开(公告)日：2016-03-17

申请号：US14767269

申请日：2014-02-26

Applicant: CJ CHEILJEDANG CORPORATION

Inventor： Bo Kyung SON ,  Gi Duk BAE ,  Jae Won KIM

IPC: C12N7/00 ,  A61K35/76

CPC classification number: C12N7/00 ,  A61K35/76 ,  C12N2795/10321 ,  C12N2795/10331 ,  C12N2795/10332

Abstract: Provided is a novel bacteriophage ΦCJ21 (KCCM11363P). In addition, the present invention relates to an antibacterial composition including the bacteriophage ΦCJ21 (KCCM11363P) as an active ingredient. Further, provided is a method of preventing and/or treating infectious diseases by Clostridium perfringens in animals except for humans using the bacteriophage ΦCJ21 (KCCM11363P) or the antibacterial composition containing the bacteriophage ΦCJ21 (KCCM11363P) as an active ingredient.

Abstract translation: 提供了一种新型噬菌体ΦCJ21（KCCM11363P）。 此外，本发明涉及包含噬菌体ΦCJ21（KCCM11363P）作为活性成分的抗菌组合物。 此外，提供了使用噬菌体ΦCJ21（KCCM11363P）或含有噬菌体ΦCJ21（KCCM11363P）的抗菌组合物作为活性成分的除了人以外的动物中的产气荚膜梭菌的感染性疾病的预防和/或治疗的方法。